P. Clouet

1.1k total citations · 1 hit paper
10 papers, 869 citations indexed

About

P. Clouet is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, P. Clouet has authored 10 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 2 papers in Surgery. Recurrent topics in P. Clouet's work include Lung Cancer Treatments and Mutations (4 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Lung Cancer Research Studies (3 papers). P. Clouet is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Lung Cancer Research Studies (3 papers). P. Clouet collaborates with scholars based in France, Japan and United States. P. Clouet's co-authors include Jean‐Pierre Armand, Philippe Rougier, Michel Ducreux, Antoine Adenis, J. Bonneterre, M Forni, A Ducoloné, B Lebeau, Jean-Luc Breton and D. Debieuvre and has published in prestigious journals such as Annals of Oncology, European Journal of Cancer and Lung Cancer.

In The Last Decade

P. Clouet

10 papers receiving 829 citations

Hit Papers

A phase II study 2000 2026 2008 2017 2000 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Clouet France 8 497 421 208 122 120 10 869
Michela Manzotti Italy 18 548 1.1× 411 1.0× 185 0.9× 264 2.2× 189 1.6× 27 956
K.K. Ang United States 15 580 1.2× 508 1.2× 390 1.9× 302 2.5× 128 1.1× 59 1.4k
Myung Hee Chang South Korea 17 385 0.8× 246 0.6× 131 0.6× 118 1.0× 81 0.7× 50 718
Dai Ikebe Japan 15 295 0.6× 259 0.6× 136 0.7× 252 2.1× 100 0.8× 26 912
G. Klouvas Greece 15 734 1.5× 348 0.8× 93 0.4× 245 2.0× 84 0.7× 42 1.1k
Nancy Chan United States 16 373 0.8× 241 0.6× 208 1.0× 302 2.5× 148 1.2× 55 868
Rosemary Mazanet United States 12 433 0.9× 187 0.4× 64 0.3× 141 1.2× 69 0.6× 29 741
Michele De Nictolis Italy 19 326 0.7× 269 0.6× 219 1.1× 333 2.7× 264 2.2× 52 1.3k
Madan L. Arora United States 13 460 0.9× 192 0.5× 297 1.4× 64 0.5× 83 0.7× 30 789
Sarah Dumont France 16 309 0.6× 386 0.9× 97 0.5× 158 1.3× 116 1.0× 64 783

Countries citing papers authored by P. Clouet

Since Specialization
Citations

This map shows the geographic impact of P. Clouet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Clouet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Clouet more than expected).

Fields of papers citing papers by P. Clouet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Clouet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Clouet. The network helps show where P. Clouet may publish in the future.

Co-authorship network of co-authors of P. Clouet

This figure shows the co-authorship network connecting the top 25 collaborators of P. Clouet. A scholar is included among the top collaborators of P. Clouet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Clouet. P. Clouet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Gervais, R., A Ducoloné, Jean-Luc Breton, et al.. (2004). Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC). Annals of Oncology. 16(1). 90–96. 104 indexed citations
3.
Quoix, Élisabeth, B Lebeau, A Depierre, et al.. (2003). Randomised, multicentre phase II study assessing two doses of docetaxel (75 or 100 mg/m2) as second-line monotherapy fornon-small-cell lung cancer. Annals of Oncology. 15(1). 38–44. 36 indexed citations
4.
Fantino, O., et al.. (2002). [MR imaging of anatomical variants of ligaments, muscles and tendons at the ankle].. PubMed. 83(1). 27–38. 17 indexed citations
5.
Rougier, Philippe, Antoine Adenis, Michel Ducreux, et al.. (2000). A phase II study. European Journal of Cancer. 36(8). 1016–1025. 609 indexed citations breakdown →
6.
Clouet, P., et al.. (1997). Imaging of thoracic and lumbar spinal extradural arachnoid cysts: report of two cases. Neuroradiology. 39(3). 203–206. 45 indexed citations
7.
Clouet, P., et al.. (1997). [Aortocaval fistula. Diagnosis using spiral x-ray computed tomography with 2D and 3D reconstructions].. PubMed. 78(11). 1159–61. 2 indexed citations
8.
Robinet, G., Phillip A. Thomas, M. Pérol, et al.. (1997). 156 Phase II study of docetaxel (Taxotere®) in 1st and 2nd line NSCLC. Lung Cancer. 18. 42–42. 6 indexed citations
9.
Sellal, François, et al.. (1997). [Imaging of limbic paraneoplastic encephalitis].. PubMed. 78(1). 73–6. 8 indexed citations
10.
Roth, Toni C., et al.. (1996). Giant-cell tumour of the sphenoid bone: case report. Neuroradiology. 38(7). 650–653. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026